Page results
-
A guide to wigs and other headwear for UCLH patients.
-
CAR T-cell therapy is a cutting-edge treatment for certain blood cancers, offering new hope to patients whose illness hasn’t responded to standard treatments. University College London Hospitals (UCLH) is proud to be one of Europe’s leading centres for this advanced care.
-
Information and advice on sleeping to help prevent sudden infant deaths or cot death.
-
This service caters for babies, children and adolescents (attending the AVM and ENT departments at the Royal National ENT & Eastman Dental Hospitals) with congenital or acquired deafness or auditory processing disorders. The service provides assessment and advice only.
-
At University College Hospital education is provided for inpatients of school age on the paediatric floor (T11) and the adolescent floor (T12).
-
Our non-emergency patient transport service is provided by G4S. G4S may use approved external sub-contractors to meet the demand of the service and/or the specific needs of our patients.
-
The Royal National Ear Nose and Throat Hospital is a national and international centre for voice disorders. The voice service includes four consultant laryngologists, eight speech and language therapists and specialist nurses.
-
The cochlear implant programme was founded in 1982, and we were the first clinical cochlear implant programme in the UK. The team has been involved with the successful implantation of more than 2,000 patients, both adults and children, from all over the UK.
-
UCLH provides an audiological service for GPs who would like to refer patients for age related audiological assessments.
-
The snoring and sleep disorders clinic offers, out-patient consultation including flexible endoscopy to assess upper airway collapse. Multidisciplinary team involvement for planning treatment.
File results
-
FOI/2023/0295 - Strikes and Trust use of the BMA rate card
-
FOI/2023/0296 - Consultant workforce information
-
FOI/2023/0300 - Post-mortem examinations for 2019, 2020, 2021 and 2022
-
FOI/2023/0301 - Meat served at the Trust that may contain nitrates or nitrites
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide
-
FOI/2023/0315 - Menopause Lead at the Trust